Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × lurtotecan × Clear all

NCT00046800 2011-10-20

Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms